SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-19-000664
Filing Date
2019-09-09
Accepted
2019-09-09 14:04:49
Documents
2
Group Members
ORBIMED CAPITAL GP VI LLCORBIMED ROF II LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss149521_sc13da.htm SC 13D/A 139847
2 JOINT FILING AGREEMENT ss149521_ex9901.htm EX-99.1 6943
  Complete submission text file 0000947871-19-000664.txt   148292
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 201 JONES ROAD WALTHAM MA 02451
Business Address 201 JONES ROAD WALTHAM MA 02451 781 768 3400
AVEDRO INC (Subject) CIK: 0001343304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90939 | Film No.: 191082830
SIC: 2834 Pharmaceutical Preparations